| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |